Key Innovation Leader Study

Overview

A mid-tier pharmaceutical company was awaiting FDA approval for a new indication in a therapeutic area with a target prescriber audience that was unique to their existing product pipeline. In addition to entering this unique and unfamiliar market, they were posed with an additional challenge of a tight timeline to introduce their product.

Our Solution

Harrison Hayes was asked to identify the top influential physicians in this new therapeutic area to best target speaker recruitment and detailing efforts. A KOL study to identify the physicians who influence the ?high prescribers? in this new therapeutic area was conducted.

Results

Harrison Hayes provided the client with a database of influential physicians in an easy-to-use format. The client immediately applied the KOL study findings to its ongoing speaker recruitment campaign and marketing/sales promotion efforts, all having favorable outcomes..